Regal Investment Advisors LLC Innoviva, Inc. Transaction History

Regal Investment Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$8.11 - $15.23 $1 Million - $1.88 Million	-123,552 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$10.28 - $14.38 $9,252 - $12,942	-900 Reduced 0.72%	123,552 $1.75 Million
Q3 2019 Nov 15, 2019	SELL	$10.05 - $14.55 $13,989 - $20,253	-1,392 Reduced 1.11%	124,452 $1.31 Million
Q2 2019 Jul 26, 2019	BUY	$13.1 - $14.95 $18,156 - $20,720	1,386 Added 1.11%	125,844 $1.83 Million
Q1 2019 May 09, 2019	SELL	$13.69 - $20.06 $81,729 - $119,758	-5,970 Reduced 4.58%	124,458 $1.75 Million
Q4 2018 Feb 04, 2019	SELL	$13.96 - $18.26 $43,680 - $57,135	-3,129 Reduced 2.34%	130,428 $2.28 Million
Q3 2018 Nov 05, 2018	BUY	$13.63 - $15.7 $288,806 - $332,667	21,189 Added 18.86%	133,557 $2.04 Million
Q2 2018 Aug 10, 2018	BUY	$13.44 - $17.59 $1.51 Million - $1.98 Million	112,368 New	112,368 $1.55 Million

225

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.3B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regal Investment Advisors LLC with notifications on news.